InflaRx Q2 2024 GAAP EPS €(0.24) Misses €(0.20) Estimate, Sales €6.357K May Not Be Comparable To €77.750K Estimate
Portfolio Pulse from Benzinga Newsdesk
InflaRx reported its Q2 2024 financial results, with a GAAP EPS of €(0.24), missing the estimate of €(0.20). Sales were €6.357K, which may not be comparable to the estimate of €77.750K.
August 08, 2024 | 11:35 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
InflaRx reported a Q2 2024 GAAP EPS of €(0.24), missing the estimate of €(0.20). Sales were €6.357K, which may not be comparable to the estimate of €77.750K.
The miss on both EPS and sales figures is likely to negatively impact InflaRx's stock price in the short term. The significant discrepancy in sales figures adds to the uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100